Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization.
about
Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug.Assessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineering.Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures.Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.Synthesis and characterization of Fe3O4-MPTMS-PLGA nanocomposites for anticancer drug loading and release studies.
P2860
Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Surface-modified solid lipid n ...... elopment and characterization.
@en
Surface-modified solid lipid n ...... elopment and characterization.
@nl
type
label
Surface-modified solid lipid n ...... elopment and characterization.
@en
Surface-modified solid lipid n ...... elopment and characterization.
@nl
prefLabel
Surface-modified solid lipid n ...... elopment and characterization.
@en
Surface-modified solid lipid n ...... elopment and characterization.
@nl
P2860
P356
P1433
P1476
Surface-modified solid lipid n ...... elopment and characterization.
@en
P2093
Alekha K Dash
Ambrish A Pandit
P2860
P304
P356
10.2217/NNM.11.57
P577
2011-10-01T00:00:00Z